Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Laryngopharyngeal Reflux
Interventions
DRUG

Prevacid

30mg of Lansoprazole twice daily (or placebo)for eight weeks.

Trial Locations (1)

95817

University of California Davis Medical Center, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT00864396 - Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux | Biotech Hunter | Biotech Hunter